(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SCRIPTS RX PHARMACY REIMAGINED

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

SCRIPTS RX PHARMACY REIMAGINED

ST13

US500000087293280

Class

35

Filing

87293280

Registration

5275338

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

01/21/2024

Trademark type

Combined

Nice classes

35

Filing date

01/09/2017

Registration date

08/29/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/21/2024

Last transaction

01/21/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

10/31/2016

First use in commerce

10/31/2016

Drawing code

5

Owner type

03

Owner location

Chicago, IL, US

Examiner

SMITH, REBECCA A

Law office

M10

Current location

TMO LAW OFFICE 110

Mark description

The mark consists of the word "SCRIPTS" next to a stylized "RX"; both of which are above the words "PHARMACY REIMAGINED".

Holders and representatives

Holders

Mall Pharmacy, Inc.

Representatives

Janet P. Peyton MCGUIREWOODS LLP

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Retail pharmacy services; and pharmaceutical servicesprocessing online and telephone prescription orders in retail and central fill pharmacies

Publications

History of USPTO decisions and trademark events.

17 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/21/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/21/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/21/2024

E815

TEAS SECTION 8 & 15 RECEIVED

07/27/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/29/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

08/29/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/13/2017

PUBO

PUBLISHED FOR OPPOSITION

06/13/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/24/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/07/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

04/07/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/07/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

04/07/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/07/2017

DOCK

ASSIGNED TO EXAMINER

04/03/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/14/2017

NWAP

NEW APPLICATION ENTERED

01/12/2017

Continuous trademark protection

Get notified about every new filing that threatens SCRIPTS RX PHARMACY REIMAGINED or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.